Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill

Weight-loss drugmakers Eli Lilly and Novo Nordisk fell after telehealth company Hims & Hers announced Thursday it will offer a copy of the newly launched Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.Copenhagen-listed shares of Novo dropped 7% on the news, while Eli Lilly stock fell 6.1% shortly after the opening bell.Hims & Hers stock soared 10%.Novo launched the Wegovy pill in the U.S. early January and CEO Mike Doustdar told CNBC on Wednesday that 170,000 people were already ...